Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic accuracy of biopsy urease tests for <i>Helicobacter pylori</i> infection in the gastric antrum and body.

The National medical journal of India·2018

Same author

<i>Helicobacter pylori</i>, acid secretion and serum gastrin.

The National medical journal of India·2018

Same author

Recurrent intestinal obstruction with acquired angio-oedema, due to C1-esterase inhibitor deficiency.

The Journal of the Association of Physicians of India·2015

Same author

Evaluation of Wound Healing Activity of Ethanolic Extract of Pongamia pinnata Bark.

Drug research·2015

Same author

Mononucleosis-like drug rash: an interesting case presentation.

Journal of family medicine and primary care·2014

Same author

Dr Ratanlal Harichand Kalro (1945-2013).

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2014

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Cryptogenic cirrhosis: a vanishing entity.

¹Jaslok Hospital and Research Centre, Dr. G. Deshmukh Marg, Mumbai.

The Journal of the Association of Physicians of India

|March 25, 2010

Summary

Diagnosing cirrhosis of unknown origin has declined due to identifying viral hepatitis and autoimmune causes. Better diagnostic tools now pinpoint cirrhosis etiology, improving prevention and treatment options.

Area of Science:

Hepatology
Virology
Immunology

Background:

The diagnosis of cryptogenic cirrhosis (cirrhosis of unknown etiology) has significantly decreased over recent decades.
This decline is attributed to advancements in identifying specific causes of liver disease.

Purpose of the Study:

To review the factors contributing to the reduced diagnosis of cryptogenic cirrhosis.
To highlight the impact of improved diagnostic criteria and etiological identification on patient management.

Main Methods:

Review of historical etiological discoveries for cirrhosis.
Analysis of improvements in diagnostic criteria for autoimmune hepatitis.
Consideration of the progression of nonalcoholic steatohepatitis to cirrhosis.

More Related Videos

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Main Results:

Discovery of hepatitis B virus (1965), hepatitis D virus (1977), and hepatitis C virus (1989) reduced unknown cirrhosis diagnoses.
Enhanced diagnostic scoring systems for autoimmune hepatitis further decreased cryptogenic cirrhosis diagnoses.
Recognition of nonalcoholic steatohepatitis as a progressive cause of cirrhosis also contributed.

Conclusions:

Establishing the specific etiology of cirrhosis in most patients is now achievable.
This improved etiological understanding provides enhanced opportunities for cirrhosis prevention and treatment.